Indomethacin (25mg)
Nexmet 25mg Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with food or milk to prevent stomach upset. Inform your doctor if you have any history of heart disease or stroke.Vomiting, stomach pain, nausea, and indigestion are some of the common side effects that might be observed on taking this medicine. It may also cause dizziness, drowsiness, or visual disturbances. Your doctor may regularly monitor your kidney function, liver function, and levels of blood components if you are taking this medicine for long-term treatment. Long-term use may lead to serious complications such as stomach bleeding and kidney problems.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Nexmet
10 tablets
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Nexmet 25mg Tablet is to be taken with food.
Nexmet 25mg Tablet is a non-steroidal anti-inflammatory drugs (NSAID). It works by blocking the release of certain chemical messengers that cause pain and inflammation (redness and swelling).
Related Warnings
It is unsafe to consume alcohol with Nexmet 25mg Tablet.
Nexmet 25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Nexmet 25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Nexmet 25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nexmet 25mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nexmet 25mg Tablet may be needed. Please consult your doctor.
Regular monitoring of kidney function test and potassium levels is advised while you are taking this medicine. Please consult your doctor.
Nexmet 25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Nexmet 25mg Tablet may be needed. Please consult your doctor.
No, Nexmet 25mg Tablet is neither an antibiotic nor a steroid. It belongs to non-steroidal anti-inflammatory drugs (NSAIDs) group of medicines. It is used to relieve moderate to severe pain and inflammation.
Nexmet 25mg Tablet is effective in relieving pain and inflammation. It is used to provide relief from various sorts of pain, such as sprains, strains and other injuries. It is also helpful in the treatment of different types of arthritis and gout. Along with that, it can be used to reduce pain and inflammation which follows after a surgery.
Nexmet 25mg Tablet is safe if used in the dose and duration advised by your doctor. Use it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
If you forget to use Nexmet 25mg Tablet, do not worry and continue using Nexmet 25mg Tablet as soon as you remember. However, if you are not sure and have any other doubts, please consult your doctor.
Nexmet 25mg Tablet is effective if used in the dose and duration advised by your doctor. Do not stop using it even if you see improvement in your condition. If you stop using Nexmet 25mg Tablet too early, the symptoms may return or worsen.
Some common side effects associated with Nexmet 25mg Tablet include vomiting, stomach pain, nausea and indigestion. It may also cause dizziness, drowsiness or visual disturbances. However, these side effects are usually not bothersome and resolve in some time. If they persist for a longer duration or worry you, consult your doctor.
